Menu

Growth fact(or)s

2017/2018

Scheduled market launch in USA, Australia, Brazil

CE mark approval permamem® scheduled

2016

Third bone & tissue days in Berlin

Pre-launch of first products in the USA

Straumann takes over exclusive distribution of botiss products in Germany

2015

Market launch of maxgraft® cortico

botiss participation at 8 ITI congresses worldwide

2014

Pharmaceutical approval for maxgraft® and for maxgraft® bonebuilder

Second bone & tissue days in Berlin with 800 participants

Worldwide cooperation with Straumann in the field of regenerative products

2013

Exclusive cooperation with the Charité tissue bank for the dental regeneration

2012

First bone & tissue days in Berlin

2011

CE mark approval for mucoderm® and for maxresorb® inject

Acquisition of Cells+Tissubank Austria

2010

CE mark approval for collprotect® membrane

2009

CE mark approcal for Jason® membrane

2008

Establishment of botiss medical AG

2007

CE mark approval for maxresorb®

2002

CE mark approval for cerabone®, employed since 2006 in the dental field